Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.
2.

Soluble adhesion molecules in serum throughout the menstrual cycle.

Bonello N, Norman RJ.

Hum Reprod. 2002 Sep;17(9):2272-8.

3.

Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.

De Caterina R, Basta G, Lazzerini G, Dell'Omo G, Petrucci R, Morale M, Carmassi F, Pedrinelli R.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2646-54.

4.

Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.

Oger E, Alhenc-Gelas M, Plu-Bureau G, Mennen L, Cambillau M, Guize L, Pujol Y, Scarabin P.

Thromb Res. 2001 Jan 15;101(2):35-43.

PMID:
11342204
6.

Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.

Liakopoulos V, Eleftheriadis T, Kyropoulos T, Voliotis G, Potamianos S, Zengos N, Stefanidis I, Heintz B.

Ren Fail. 2005;27(3):315-21.

PMID:
15957549
7.

Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules.

Van Baal WM, Emeis JJ, Kenemans P, Kessel H, Peters-Muller ER, Schalkwijk CG, van der Mooren MJ, Stehouwer CD.

Eur J Clin Invest. 1999 Nov;29(11):913-21.

PMID:
10583435
8.

Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-alpha, and interleukin-6 in in vitro fertilization cycles.

Souter I, Huang A, Martinez-Maza O, Breen EC, Decherney AH, Chaudhuri G, Nathan L.

Fertil Steril. 2009 May;91(5 Suppl):2012-9. doi: 10.1016/j.fertnstert.2008.04.039. Epub 2008 Sep 7.

PMID:
18778820
9.

Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.

Lussier-Cacan S, Xhignesse M, Desmarais JL, Davignon J, Kafrissen ME, Chapdelaine A.

Metabolism. 1991 Aug;40(8):849-54.

PMID:
1907348
11.

Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients.

Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayama S.

Diabetes. 1997 Dec;46(12):2096-101.

PMID:
9392502
12.

Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.

Wang AY, Lam CW, Wang M, Woo J, Chan IH, Lui SF, Sanderson JE, Li PK.

Am J Kidney Dis. 2005 Apr;45(4):715-29.

PMID:
15806475
13.

Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas.

Christiansen I, Sundström C, Kälkner KM, Bring J, Tötterman TH.

Eur J Haematol. 1998 Nov;61(5):311-8. Corrected and republished in: Eur J Haematol. 1999 Mar;62(3):202-9.

PMID:
9855246
14.

Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 are increased in women with ovarian hyperstimulation syndrome.

Daniel Y, Geva E, Amit A, Baram A, Englander T, Kupferminc MJ, Fait G, Lessing JB.

Fertil Steril. 1999 May;71(5):896-901.

PMID:
10231053
15.

Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants.

Palan PR, Magneson AT, Castillo M, Dunne J, Mikhail MS.

Am J Obstet Gynecol. 2006 May;194(5):e35-8. Epub 2006 Apr 21.

PMID:
16647895
16.

Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.

Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kübler W, Bode C.

Arterioscler Thromb Vasc Biol. 1997 Mar;17(3):505-12.

18.
Items per page

Supplemental Content

Write to the Help Desk